360 Participants Needed

Integrative Pain Management for Chronic Pain

(IPMP+ Trial)

JW
Overseen ByJulia Wu, MPH
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of California, San Francisco
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of this treatment for chronic pain?

Research shows that integrative pain management programs, which include acupuncture and other therapies, help patients manage chronic pain by reducing medication use and improving psychological resilience and social connections. Acupuncture is recommended by international guidelines for chronic pain management, and group acupuncture can increase access and reduce costs.12345

Is integrative pain management, including acupuncture, safe for humans?

Acupuncture, a component of integrative pain management, is generally considered safe, but there have been reports of serious adverse effects like pneumothorax (collapsed lung) and infections. While these incidents are rare, they highlight the importance of receiving treatment from qualified practitioners.34678

How does the Integrative Pain Management treatment differ from other treatments for chronic pain?

This treatment is unique because it combines multiple non-drug approaches like acupuncture, mindfulness, and group medical visits to address both the physical and psychosocial aspects of chronic pain, helping patients reduce medication use and improve social connections.2391011

What is the purpose of this trial?

Socioeconomically disadvantaged populations have a high prevalence of chronic pain, exacerbated by social isolation, intersectional stigma, and disparities in pain assessment and treatment options. Effective interventions using a multilevel, biopsychosocial approach are needed to decrease the unequal burden of pain. The proposed study will test group-based integrative models of pain management in primary care safety net clinics to improve pain care for racially and ethnically diverse low-income patients.

Research Team

MC

Maria Chao, DrPH, MPA

Principal Investigator

University of California, San Francisco

Eligibility Criteria

This trial is for individuals from low-income backgrounds who are experiencing chronic pain and receive care at primary safety net clinics. It aims to help those affected by social isolation, stigma, and disparities in pain management.

Inclusion Criteria

Intent to be available for up to 24 weeks
I can provide a contact phone number.
I visited my doctor for chronic pain in the last 6 months.
See 3 more

Exclusion Criteria

I have participated in a group pain management program recently.
I am able to understand and consent to my medical treatment.
I have had acupuncture for pain within the last 3 months.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either Integrative Group Medical Visits (IGMV), group acupuncture, both, or usual care for 12 weeks

12 weeks
Weekly group sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment

12 weeks
2 visits (in-person)

Final Follow-up

Final assessment of outcomes including pain impact and social support

6 months after baseline

Treatment Details

Interventions

  • Group Acupuncture
  • Integrative Group Medical Visits
Trial Overview The study is testing two group-based treatments: acupuncture and integrative group medical visits. These approaches are designed to address chronic pain using a comprehensive model that considers biological, psychological, and social factors.
Participant Groups
4Treatment groups
Experimental Treatment
Active Control
Group I: Integrative Group Medical Visits (IGMV)Experimental Treatment1 Intervention
IGMV will consist of a 12-week program that provides education on the biopsychosocial model of pain and multimodal treatments; physical movement; mindfulness training; and peer support. Non-pharmacologic approaches are based on guidelines on chronic pain management; feedback of experts, staff, and patients; and feasibility with the greatest potential to benefit participants. Participants will receive a binder with educational materials.
Group II: Group Acupuncture and IGMVExperimental Treatment2 Interventions
Both group acupuncture and IGMV. Along with usual care, participants will be offered weekly group acupuncture treatments and integrative group medical visits as described above.
Group III: Group AcupunctureExperimental Treatment1 Intervention
Participants randomized to acupuncture will receive 12 weeks of acupuncture treatments delivered in a group setting, dosing similar to prior research. Acupuncture point selection and other treatment details will follow responsive manualization, a protocol developed for the largest clinical trial of group acupuncture to date. A licensed acupuncturist experienced with administering group acupuncture treatments will determine each participant's traditional Chinese medicine diagnosis and administer 8-10 acupuncture needles on distal points of participant's body (below the knees, from the elbows to the hands, and on the head). Duration of assessment, needle placement and retention will be 30-45 minutes. Details of acupuncture treatments (e.g., frequency and duration, traditional Chinese medicine diagnosis, number of needles and points used) will be documented in electronic health records.
Group IV: Usual CareActive Control1 Intervention
Participants will receive care as usual provided through their primary care providers. Usual care includes medical diagnostic evaluation, analgesic drug therapies, recommendations for physical activity, and sometimes referral to specialist physicians or physical therapy. Usual care was chosen as a comparison arm for this study because it is practical and clinically relevant. Participants randomized to usual care will be put on a waitlist and can access group acupuncture or IGMV after their final study visit.

Group Acupuncture is already approved in United States, European Union, China, Canada for the following indications:

🇺🇸
Approved in United States as Acupuncture for:
  • Chronic Pain Management
  • Pain Relief
🇪🇺
Approved in European Union as Acupuncture Therapy for:
  • Pain Management
  • Migraines
  • Tension Headaches
🇨🇳
Approved in China as Traditional Chinese Medicine Acupuncture for:
  • Chronic Pain
  • Neck Pain
  • Back Pain
  • Migraines
🇨🇦
Approved in Canada as Acupuncture Treatment for:
  • Pain Relief
  • Chronic Pain Management
  • Migraines

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, San Francisco

Lead Sponsor

Trials
2,636
Recruited
19,080,000+

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator

Trials
473
Recruited
1,374,000+

Findings from Research

Acupuncture is recommended by various international clinical guidelines as an effective option for managing chronic pain, placing it on par with conventional treatments.
This article emphasizes that acupuncture should be considered early in the treatment process for chronic pain, rather than as a last resort, and provides guidance for primary care physicians on how to refer patients for acupuncture.
[Acupuncture and chronic pain : practical considerations for primary care physicians].Zurron, N., Lanier, C., Berna-Renella, C.[2020]
The Pain & Wellness Centre (PWC) in Vaughan, Ontario, successfully implemented a publicly funded interdisciplinary pain management program, serving over 1,000 new patients and demonstrating significant improvements in patient outcomes after 3 months.
This model of care, based on the biopsychosocial approach, showcases the feasibility of providing effective chronic pain management in community settings, aligning with the Ontario Ministry of Health's comprehensive pain strategy.
From (Ontario Ministry of Health and Long-Term Care) policy to implementation: A retrospective look at a community-based patient-centered model of care for chronic pain.Mailis, A., Lakha, SF.[2022]
The Integrative Pain Management Program (IPMP), a 12-week multimodal approach, helped 41 low-income patients with chronic pain develop new strategies for pain management, leading to reduced medication use and increased psychological resilience.
Participants reported feeling more hopeful and socially connected after completing the program, highlighting the effectiveness of addressing psychosocial factors in chronic pain management within primary care settings.
Vulnerable Patients' Psychosocial Experiences in a Group-Based, Integrative Pain Management Program.Bruns, EB., Befus, D., Wismer, B., et al.[2023]

References

[Acupuncture and chronic pain : practical considerations for primary care physicians]. [2020]
From (Ontario Ministry of Health and Long-Term Care) policy to implementation: A retrospective look at a community-based patient-centered model of care for chronic pain. [2022]
Vulnerable Patients' Psychosocial Experiences in a Group-Based, Integrative Pain Management Program. [2023]
"It's Better in a Group Anyway": Patient Experiences of Group and Individual Acupuncture. [2023]
Interdisciplinary chronic pain management: past, present, and future. [2022]
Does Offering Battlefield Acupuncture Lead to Subsequent Use of Traditional Acupuncture? [2023]
Acupuncture: does it alleviate pain and are there serious risks? A review of reviews. [2022]
Patient safety incidents from acupuncture treatments: a review of reports to the National Patient Safety Agency. [2016]
The Latino Integrative Medical Group Visit as a Model for Pain Reduction in Underserved Spanish Speakers. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Interdisciplinary treatment of chronic pain. [2019]
Long term outcomes of chronic pain patients attending a publicly funded community-based interdisciplinary pain program in the Greater Toronto area: results of a practice-based audit. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security